United Therapeutics Corp Fireside Chat Hosted By JPMorgan Transcript
Good morning, everyone. I'm Dewey Steadman with United Therapeutics. And I'm happy today to present or to host or at least introduce Jessica Fye from JPMorgan who will be hosting our fireside chat with the management team today.
Before we start, I just want to remind you that we may make forward-looking statements today, and any risks and uncertainties are listed in our SEC filings, including Forms 10-K and 10-Q.
And with that, I'll turn it over to Jess.
Great. Thanks, Dewey, and welcome, everyone. Happy New Year. I'm Jess Fye. I'm a biotech analyst at JPMorgan. Delighted to be joined today by United Therapeutics senior management team, including the company's Chairperson and CEO, Dr. Martine Rothblatt, as well as the company's President and COO, Michael Benkowitz. So thank you so much for spending this time with us this morning.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |